Perfluorochemical Emulsion

Perfluorochemical emulsion is indicated to prevent or diminish myocardial ischemia, as manifested by decreased ventricular wall motion and global ejection fraction, occurring during percutaneous transluminal coronary angioplasty (PTCA) in patients at high risk of ischemic complications of angioplasty.

Brands

Adult Dose

Neonatal

Paedriatic

Characteristics

Contraindications

Perfluorochemical Emulsion is contraindicated in conditions like Hypersensitivity to any component of product.

Effects

The severe or irreversible adverse effects of Perfluorochemical Emulsion, which give rise to further complications include Hypotension, Bradycardia, Ventricular tachycardia, Ventricular fibrillation, Dyspnea.The symptomatic adverse reactions produced by Perfluorochemical Emulsion are more or less tolerable and if they become severe, they can be treated symptomatically, these include Chills, Urticaria, Nausea and vomiting, Back pain.

Indications

Perfluorochemical Emulsion is primarily indicated in conditions like Myocardial ischaemia.

Interactions

No data regarding the interactions of Perfluorochemical Emulsion was found.

Interfrence

Risks

Drug should not be given to Paediatrics, Pregnant Mothers, patients suffering from Kidney dysfunction, patients suffering from Liver Malfunction, Geriatrics, and Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Storage

Warnings

Back to List

Any information that appears on this website page is provided for the purpose of general information. This website has been compiled in good faith by HMIS.Online. However, no guarantee is made as to the completeness, validity or accuracy of the information it contains.